Company

Mabworks Biotech

As of the edition of 20 October 2026, Mabworks Biotech runs 5 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active4
Went quiet1
Total5

Where its trials are

  • Immune system: 6 trials led
  • Cancer: 3 trials led
  • Blood and lymph: 2 trials led